Skip to content
HowShorted

AERIE PHARMACEUTICALS INC short interest in 2019

In 2019, AERIE PHARMACEUTICALS INC's disclosed short interest ran from 9.89% of shares outstanding on 15 Jan 2019 to 28.69% on 31 Dec 2019, a change of +18.80 percentage points. The year's high was 32.58% on 31 Oct 2019 and its low 8.74% on 15 May 2019, averaging 17.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.63 days on 29 Nov 2019. Full history: AERIE PHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for AERIE PHARMACEUTICALS INC in 2019

2019 in figures

Start of year
9.89% (15 Jan 2019)
End of year
28.69% (31 Dec 2019)
Change
+18.80 pp
High
32.58% (31 Oct 2019)
Low
8.74% (15 May 2019)
Average
17.67%
Highest days to cover
19.63 (29 Nov 2019)
SEC filings marked
8

Every report in 2019

AERIE PHARMACEUTICALS INC short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20199.89%10.56
31 Jan 201912.10%10.36
15 Feb 201911.17%6.28
28 Feb 20199.33%3.84results (8-K)
15 Mar 20199.07%5.6510-K filed
29 Mar 20199.14%8.08
15 Apr 20199.28%8.45
30 Apr 20198.87%7.03
15 May 20198.74%5.65results (8-K), 10-Q filed
31 May 20198.91%10.07
14 Jun 201910.49%7.34
28 Jun 201911.80%7.37
15 Jul 201912.41%6.84
31 Jul 201915.08%7.56
15 Aug 201918.12%6.82results (8-K), 10-Q filed
30 Aug 201920.01%15.75
13 Sep 201926.01%5.56
30 Sep 201926.81%12.14
15 Oct 201930.24%7.88
31 Oct 201932.58%14.46
15 Nov 201931.86%9.26results (8-K), 10-Q filed
29 Nov 201931.82%19.63
13 Dec 201931.72%18.11
31 Dec 201928.69%13.03

See also: AERIE PHARMACEUTICALS INC's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.